Table 2.
Total (n=150) | No Auto (n=100) | Prior Auto (n=50) | |
---|---|---|---|
Grade II-IV acute GVHD at day 100, % | 27 | 25 | 30 |
Grade III-IV acute GVHD at day 100, % | 4 | 2 | 8 |
Chronic extensive GVHD (5 years), % | 48 | 44 | 56 |
NRM (1/5 years), % | 9/13 | 12/16 | 4/6 |
Relapse/Progression (1/5 years), % | 35/50 | 31/43 | 42/64 |
Overall Survival (1/5 years), % | 73/53 | 73/55 | 74/48 |
PFS (1/5 years), % | 56/37 | 57/41 | 54/30 |
Data are survival or cumulative incidence percentage. Study was not designed to compare outcomes between no auto and prior auto groups.
Abbreviations: GVHD, graft-versus-host-disease; NRM, non-relapse mortality; PFS, progression-free survival